Background Coverage levels for many recommended adult vaccinations are low. The cost-
effectiveness research literature on adult vaccinations has not been synthesized in recent …

Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …

Abstract Background and Aims The effectiveness and safety of vaccinations can be altered
by immunosuppressive therapies, and perhaps by inflammatory bowel disease (IBD) itself …

This updated Fifth Edition provides comprehensive coverage of the biology of gynecologic
cancer, the therapeutic modalities available, and the diagnosis and treatment of site-specific …

Background Incremental cost-effectiveness and cost-utility analyses [health economic
evaluations (HEEs)] of vaccines are routinely considered in decision making on …

Background Increasingly, countries have introduced female vaccination against human
papillomavirus (HPV), causally linked to several cancers and genital warts, but few have …

Bulgaria is among the European Union (EU) countries with the highest burden of cervical
cancers and life expectancy below the EU average. The majority of cervical cancer cases …

Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …

Background. Men who have sex with men (MSM) have a high lifetime risk of anogenital
warts and cancers related to infection with human papillomavirus (HPV). They also benefit …

Counseling messages for tobacco cessation, condom use, circumcision, and selective
choice in the number of sexual partners can help reduce the risk of cervical cancer. Other …